Osteoporosis

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Huntsville, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Montgomery, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Peoria, Arizona, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Beverly Hills, California, United States

• Osteocentrum FN — Hradec Králové, Czechia
• Osteocentrum 3 .Interni Klinika 1. LFUK a VFN — Prague, Czechia
• Drug Research Center — Balatonfüred, Hungary
• Semmelweis University Department of Orthopedic — Budapest, Hungary

• University San Carlos Hospital — Madrid, Spain

• CHU Clermont-Ferrand — Clermont-Ferrand, France

• Research Site — Ljubljana, Slovenia

• GSK Investigational Site — Port Orange, Florida, United States

• GSK Investigational Site — Singapore

• GSK Investigational Site — Madison, Wisconsin, United States

Not specified

• Pfizer Investigational Site — Buenos Aires, Argentina
• Pfizer Investigational Site — Buenos Aires, Argentina
• Pfizer Investigational Site — Capital Federal - Buenos Aires, Argentina